Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells
Zheqi Li(University of Pittsburgh), Adrian V. Lee(University of Pittsburgh)
Cited by 45
Related Papers
Hotspot <i>ESR1</i> Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
|Cancer Research|2022|80
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
|Nature Communications|2022|72
Loss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast Carcinoma
|Molecular Cancer Research|2022|23
Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors
|Journal of Biological Chemistry|2018|16
Transcriptomic analysis identifies enrichment of cAMP/PKA/CREB signaling in invasive lobular breast cancer
|Breast Cancer Research|2024|7